Categories
Global Marketing Strategies

Cerebrospinal Fluid (CSF) Management Market Set to Reach USD 3.8 Billion by 2031, Driven by Advancements in Medical Devices and Growing Neurological Disorder Prevalence – Market Research Intellect | PR Newswire [Video]

The growth of the Cerebrospinal Fluid (CSF) Management Market is primarily driven by the rising incidence of neurological disorders such as hydrocephalus, brain injuries, and spinal cord conditions, which require effective management. Advancements in medical devices, including innovative CSF shunts and drainage systems, have improved treatment outcomes, further driving market expansion.

, /PRNewswire/ — The global Cerebrospinal Fluid (CSF) Management Market is expected to grow from USD 2.5 billion in 2024 to USD 3.8 billion by 2031, at a compound annual growth rate (CAGR) of 6.2%. This growth is driven by the increasing prevalence of neurological conditions, advancements in CSF management devices, and rising awareness of timely treatment for disorders like hydrocephalus.

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1038984

202 – Pages

126 – Tables

37 – Figures

Scope Of The Report

REPORT ATTRIBUTES

DETAILS

STUDY PERIOD

2020-2031

BASE YEAR

2023

FORECAST PERIOD

2024-2031

HISTORICAL PERIOD

2020-2023

UNIT

Value (USD Billion)

KEY COMPANIES PROFILED

Medtronic, Johnson & Johnson, Integra LifeSciences, Spiegelberg, Codman & Shurtleff (Johnson & Johnson), B. …

Watch/Read More